Combining antivirals and immunomodulators to fight COVID-19 / Vincent Feuillet [ansd two others]

In: Trends Immunol . 2021 Jan; 42 (1) pages:31-44.
doi: 10.1016/j.it.2020.11.003


Angiotensin-Converting Enzyme 2-- immunology
Angiotensin-Converting Enzyme 2--metabolism
Antiviral Agents --therapeutic use
COVID-19 --drug therapy
COVID-19 --virology
mmunologic Factors-- immunology
Immunologic Factors --metabolism
SARS-CoV-2 --drug effects